ProPhase Labs (PRPH) Non-Current Deffered Revenue (2019 - 2026)
ProPhase Labs' Non-Current Deffered Revenue came in at $348,000 for Q2 2026, down 46.8% from $654,000 a year earlier and down 55.8% from the prior quarter.
Powered by 
Analysis
ProPhase Labs (PRPH) Non-Current Deffered Revenue (2019 - 2026) Analysis & Trends
At the end of FY2025, ProPhase Labs' Non-Current Deffered Revenue was $643,000, down 18.0% from FY2024.
- Non-Current Deffered Revenue carries a five-year compound annual growth rate of 31.7% (FY2020 to FY2025).
- Going back by year, Non-Current Deffered Revenue was $784,000 in FY2024 (-28.7%), $1.1 million in FY2023 (+3.9%), $1.06 million in FY2022 (+17.0%) and $905,000 in FY2021 (+458.6%).
- The Q2 2026 figure represents the lowest quarterly Non-Current Deffered Revenue since Q3 2021.
- Year-over-year, Non-Current Deffered Revenue increased in two of the last eight quarters, with an average decline of 20.8%.
- The fastest year-over-year change in Non-Current Deffered Revenue over five years came in Q3 2022 (growth of 774.5%), and the weakest in Q2 2026 (a decline of 46.8%).
- Business Quant data shows PRPH's Non-Current Deffered Revenue at $788,000 (Q1 2026), $643,000 (Q4 2025) and $589,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | ProPhase Labs | 155,925.56 | -390,074.44 | 226,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 348,000.00 |
| Mar 31, 2026 | 788,000.00 |
| Dec 31, 2025 | 643,000.00 |
| Sep 30, 2025 | 589,000.00 |
| Jun 30, 2025 | 654,000.00 |
| Mar 31, 2025 | 739,000.00 |
| Dec 31, 2024 | 784,000.00 |
| Sep 30, 2024 | 928,000.00 |
| Jun 30, 2024 | 893,000.00 |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 796,000.00 |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | 1.16 Mn |
| Dec 31, 2022 | 1.06 Mn |
| Sep 30, 2022 | 927,000.00 |
| Jun 30, 2022 | 983,000.00 |
| Mar 31, 2022 | 858,000.00 |
| Dec 31, 2021 | 905,000.00 |
| Sep 30, 2021 | 106,000.00 |
API Access
ProPhase Labs Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=PRPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "PRPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=PRPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();